Biodesix, Inc.
BDSX
$0.50
-$0.049-8.93%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 17.67% | 30.82% | 32.66% | 31.37% | 20.32% |
| Total Depreciation and Amortization | 4.83% | -3.74% | -14.30% | -13.21% | -5.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.35% | -36.36% | -27.45% | -37.83% | -34.31% |
| Change in Net Operating Assets | -291.69% | -256.27% | -268.77% | -145.75% | 360.22% |
| Cash from Operations | -112.72% | -152.21% | -72.26% | 22.91% | 49.15% |
| Capital Expenditure | 85.91% | 75.42% | 34.61% | -44.48% | -594.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -46.85% | 0.55% | 6.67% | 13.64% | 39.41% |
| Cash from Investing | 85.08% | 74.80% | 34.31% | -43.54% | -552.57% |
| Total Debt Issued | -- | -66.67% | -66.67% | -77.78% | -77.83% |
| Total Debt Repaid | -4.08% | 99.78% | 99.80% | 99.83% | 99.83% |
| Issuance of Common Stock | 94.99% | 19.64% | 90.48% | -50.02% | -52.03% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 56.89% | 65.96% | 40.24% | 56.02% | 45.54% |
| Cash from Financing | 78.69% | 50.17% | 146.80% | -45.46% | -50.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.77% | 147.88% | 321.99% | -255.78% | -261.94% |